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ABSTRACT Mycoplasma bovis is a leading cause of pneumonia in modern calf rear-
ing. Fast identification is essential to ensure appropriate antimicrobial therapy.
Therefore, the objective of this study was to develop a protocol to identify M. bovis
from bronchoalveolar lavage fluid (BALf) with matrix-assisted laser desorption ioniza-
tion–time of flight mass spectrometry MALDI-TOF MS and to determine the diagnos-
tic accuracy in comparison with other techniques. BALf was obtained from 104 cat-
tle, and the presence of M. bovis was determined in the following three ways: (i)
rapid identification of M. bovis with MALDI-TOF MS (RIMM) (BALf was enriched and
after 24, 48, and 72 h of incubation and was analyzed using MALDI-TOF MS), (ii) tri-
plex real-time PCR for M. bovis, Mycoplasma bovirhinis, and Mycoplasma dispar, and
(iii) 10-day incubation on selective-indicative agar. The diagnostic accuracy of the
three tests was determined with Bayesian latent class modeling (BLCM). After 24 h
of enrichment, M. bovis was identified with MALDI-TOF MS in 3 out of 104 BALf
samples. After 48 and 72 h of enrichment, 32/104 and 38/100 samples, respectively,
were M. bovis positive. Lipase-positive Mycoplasma-like colonies were seen in 28 of
104 samples. Real-time PCR resulted in 28/104 positive and 12/104 doubtful results
for M. bovis. The BLCM showed a sensitivity (Se) and specificity (Sp) of 86.6% (95%
credible interval [CI], 69.4% to 97.6%) and 86.4% (CI, 76.1 to 93.8) for RIMM. For real-
time PCR, Se was 94.8% (CI, 89.9 to 97.9) and Sp was 88.9% (CI, 78.0 to 97.4). For
selective-indicative agar, Se and Sp were 70.5% (CI, 52.1 to 87.1) and 93.9% (CI, 85.9
to 98.4), respectively. These results suggest that rapid identification of M. bovis with
MALDI-TOF MS after an enrichment procedure is a promising test for routine diag-
nostics in veterinary laboratories.
KEYWORDS Bayesian latent class model, lipase activity, Mycoplasma bovirhinis,
Mycoplasma bovis, Mycoplasma dispar
Mycoplasma bovis is one of the primary pathogens causing severe pneumonia incattle and is also associated with arthritis, otitis, mastitis, and reproductive
disorders (1, 2). Bovine respiratory disease (BRD) is the leading cause of antimicrobial
use in calves (3, 4), and M. bovis is involved in approximately 20% to 30% of pneumonia
outbreaks in conventional dairy and beef calves, and almost 100% of veal calf herds
have been in contact with this bacterium (5–7). Rapid diagnosis of M. bovis is of great
importance to rationally use antimicrobials and limit economic losses, since M. bovis is
Citation Bokma J, Van Driessche L, Deprez P,
Haesebrouck F, Vahl M, Weesendorp E,
Deurenberg RH, Pardon B, Boyen F. 2020. Rapid
identification of Mycoplasma bovis strains from
bovine bronchoalveolar lavage fluid with
matrix-assisted laser desorption ionization–
time of flight mass spectrometry after
enrichment procedure. J Clin Microbiol
58:e00004-20. https://doi.org/10.1128/JCM
.00004-20.
Editor Brad Fenwick, University of Tennessee
at Knoxville
Copyright © 2020 American Society for
Microbiology. All Rights Reserved.
Address correspondence to Jade Bokma,
jade.bokma@ugent.be.
Received 3 January 2020
Returned for modification 25 January 2020
Accepted 23 March 2020





June 2020 Volume 58 Issue 6 e00004-20 jcm.asm.org 1Journal of Clinical Microbiology
26 May 2020
 on M










inherently resistant against widely used antimicrobial agents and is difficult to eradicate
once it is chronically present (1, 8). In contrast to other Mycoplasma species, M. bovis
can be cultured quite well, although it easily takes 5 to 10 days before culture results
become available. Also, to obtain definite Mycoplasma spp. identification, other tech-
niques, such as biochemical characterization or PCR, are needed (9, 10). This is of great
importance, as M. bovis is generally recognized as a primary pathogen. However, the
pathogenic significance of other Mycoplasma species, such as M. arginini, M. bovirhinis,
and M. dispar, are more controversial, as they are isolated from both healthy and
pneumonic lungs (11–14), and incorrect identification could lead to unnecessary anti-
microbial use. Selective-indicative agar using lipase activity as an M. bovis-specific
feature has been described to distinguish M. bovis from other bovine Mycoplasma spp.
(15, 16). Unfortunately, its diagnostic performance is currently not known. PCR is the
preferred method for final identification of Mycoplasma species. We currently are
observing a shift toward PCR identification directly on the specimen, such as bron-
choalveolar lavage fluid (BALf), in the case of pneumonia. Even though this is more
rapid, due to logistic reasons, laboratories usually collect samples to perform in a
weekly or twice weekly analysis, whereupon diagnostic results still take several days.
Matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-
TOF MS) is widely used as a rapid, low cost, culture-based diagnostic tool for the
identification of bacteria, including Mycoplasma spp. (17). Nevertheless, prior isolation
of M. bovis on specific solid medium is still necessary, and final identification can take
up to 10 days (10, 18, 19). To reduce sample turnaround time, at present, there is great
interest in the identification of bacteria by MALDI-TOF MS directly from the sample or
after a short enrichment period in liquid broth as is already done for urine, blood, milk,
and BALf specimens (20–23). However, such a technique is currently not available for
Mycoplasma spp., presumably because of difficulties such as their fastidious growth and
overgrowth by other bacteria.
Therefore, the objective of this study was to develop a protocol to identify M. bovis
directly from BALf after an enrichment procedure with MALDI-TOF MS. The accuracy of
this diagnostic test was compared with real-time PCR and biochemical characterization
(lipase activity) on solid medium in a Bayesian latent class model (BLCM).
MATERIALS AND METHODS
Development of a protocol for fast MALDI-TOF detection of M. bovis in BALf. (i) Determination
of an enrichment procedure and antimicrobial concentrations. M. bovis concentration in BALf usually
ranges from 1.8  103 to 1.03  108 CFU/ml (24), whereas a minimum concentration of 1.0  108 CFU/ml
is necessary to obtain interpretable spectra with MALDI-TOF MS starting from mycoplasma grown in
broth (18, 19). Therefore, an enrichment procedure seemed necessary to identify M. bovis directly from
BALf. We explored different broths as described earlier (19) and experimented additionally with different
antimicrobials, since overgrowth of M. bovis by other bacteria, such as (fecal) contaminants (e.g.,
Enterobacteriaceae), commensals (e.g., Streptococcus, Staphylococcus, and Enterococcus) or pathogenic
bacteria (e.g., Pasteurellaceae) in liquid medium is very likely (13, 25).
Starting from a fresh culture, three M. bovis strains obtained from clinical field samples (Mb144, K6,
and K7; passaged 3 to 5 times) were cultured in modified basic pleuropneumonialike organism (PPLO)-
broth (255420; BD Difco, Berkshire, United Kingdom) with inactivated horse serum (25%; Gibco, Ireland),
and technical yeast extract (0.7%; Bacto, Belgium) supplemented with sodium pyruvate (0.5%; Sigma-
Aldrich, Germany), ampicillin sodium salt (520 g/ml; Sigma-Aldrich, Germany) (19), and colistin sulfate
(VMD, Belgium) at a concentration of 967 IU/ml, similar to what was described previously (26, 27). Then,
1 ml of the M. bovis culture with either meropenem (USP reference standard, Sigma-Aldrich, Germany) or
vancomycin (vancomycin hydrochloride from Streptomyces orientalis; Sigma-Aldrich, Germany) in final
concentrations of 32, 16, 8, 4, 2, 1, 0.5, and 0 g/ml was prepared in Eppendorf tubes at a final M. bovis
concentration of 1 to 3  104 CFU/ml (28). After 48 h of incubation (37°C, 5% CO2), protein extraction was
performed as described before (18). Antimicrobial concentrations where the MALDI-TOF MS identifica-
tion score (ID-score) for M. bovis was 1.7 were considered to not inhibit successful identification (18, 29).
The highest antimicrobial concentration that did not inhibit successful M. bovis identification with
MALDI-TOF MS was chosen for the rapid identification protocol.
(ii) Identification and enrichment protocol with MALDI-TOF MS from BALf. The final protocol is
presented in the next paragraphs as part of the diagnostic test study and will be referred to as “rapid
identification of M. bovis with MALDI-TOF MS” (RIMM).
Diagnostic test study. (i) Study population and sampling method. A prospective diagnostic test
accuracy assay was performed. To detect a difference in sensitivity of 0.90 to 0.70 with 80% power, a
minimum of 103 samples were needed (30). Therefore, a convenience sample of 104 BALf specimens was
Bokma et al. Journal of Clinical Microbiology
June 2020 Volume 58 Issue 6 e00004-20 jcm.asm.org 2
 on M










collected for diagnostic purposes as described before (31). Samples were taken from 3-week-old to
4-year-old cows originating from 10 different farms (5 beef [A to D and F], 3 dairy [E, G, and H], and 2
veal [I and J]) in Flanders, Belgium, from January 2019 to May 2019. Subsequently, samples were stored
at 4°C for 3 to 20 hours before culture-based methods (index tests: RIMM and selective-indicative agar)
were performed. All samples were stored (–20°C) before the reference test (real-time PCR) was performed
blindly. All procedures were approved by the local ethical committee under approval number EC2019-1.
(ii) Rapid identification of M. bovis with MALDI-TOF MS (RIMM). BALf was vigorously vortexed,
and 4 ml was inoculated in 8 ml modified basic PPLO broth as described above, supplemented with
32 g/ml vancomycin and 32 g/ml meropenem. After 24, 48, and 72 h of incubation (37°C, 5% CO2),
protein extraction was performed on 1 ml of the enriched BALf culture as described before, and 1 l of
lysate was spotted in triplicate on target polished steel barcode (BC) plates (18, 19). Spotted samples
were air dried and covered with 1 l alpha-cyano-4-hydroxycinnamic acid matrix (Bruker Daltonics,
Bremen, Germany). All samples were processed with an Autoflex III Smartbeam MALDI-TOF MS instru-
ment using FlexControl and MBT Compass software (Bruker Daltonics, Bremen, Germany). External
calibration and validation were performed by adding bacterial test standard as described by the
manufacturer (Bruker Daltonics, Bremen, Germany). Negative controls were performed by adding 1 l of
the matrix only. The standard library (MBT Compass server version 4.1.90 PYTH) was extended with four
in-house main spectrum profiles (MSPs) for M. bovis as outlined before (19) and extra MSPs of M.
bovirhinis (NCTC 10118), Mycoplasma ovipneumoniae (NCTC 10151), and M. dispar (NCTC 10125). Iden-
tification of Mycoplasma spp. was considered reliable at the species level when logarithmic score values
were 1.7 as proposed in previous studies (18, 29), whereas identification of nonmycoplasmal bacteria
was considered reliable at the species level when score values were 2.0 and at the genus level when
score values were 1.7 and 2.0 (20).
(iii) Selective-indicative agar. One hundred l of 10-fold dilutions of BALf was inoculated on an
in-house modified PPLO agar containing Difco PPLO agar (product number 241210) enriched with 25%
inactivated horse serum (Gibco), 0.7% technical yeast extract (Bacto), 0.5% D-()-glucose monohydrate
(Sigma-Aldrich), 520 g/ml ampicillin sodium salt (Sigma-Aldrich), 967 IU/ml colistin sulfate (VMD), and
0.1% Tween 80 (polysorbate 80; Sigma-Aldrich). Tween 80 was added for observing lipase activity as an
indicator for M. bovis (15, 16). After 1 to 10 days of incubation (37°C, 5% CO2), presumptive Mycoplasma
colonies (fried egg morphology) were identified as M. bovis based on the presence of lipase activity,
observed as an “oil-like” film surrounding the colonies, and were counted.
(iv) Triplex real-time PCR. A previously described triplex real-time PCR was chosen as the reference
test, as this method showed results comparable to other PCR methods used for routine diagnostics to
identify M. bovis from BALf (32, 33). The limit of detection was determined at 30 CFU/ml for M. bovis and
M. bovirhinis and 300 CFU/ml for M. dispar as described previously (32). BALf samples were thawed before
DNA extraction. After vortexing, 200 l of sample was used for DNA extraction with the MagNA Pure 96
Instrument (Roche) using the MagNA Pure 96 DNA and viral NA small volume kit (Roche) for DNA
extraction. Then, 5 l extracted DNA was used for the triplex real-time PCR detecting M. bovis, M. dispar,
and M. bovirhinis as described before (32). Fresh M. bovis, M. dispar, and M. bovirhinis cultures from
in-house reference strains were used as an internal control to monitor DNA extraction, as well as
inhibition of the PCRs. Threshold cycle (CT) values were interpreted as positive (35), doubtful (35 to 40),
or negative (40) as previously described (33).
(v) Conventional bacterial culture for nonmycoplasmal bacteria. An essential part of the protocol
was to avoid overgrowth of M. bovis by other pathogens. Therefore, to quantify other fast-growing
nonmycoplasmal pathogens and the contamination present in the BALf samples, 100 l of 10-fold
dilutions of BALf was cultured on Columbia agar supplemented with 5% sheep blood (blood agar; Oxoid,
UK). Nonmycoplasmal bacteria were identified with MALDI-TOF MS after 1 day of incubation (37°C, 5%
CO2). Additionally, after 72 h of enrichment in the BALf in modified PPLO medium, 50 l was cultured on
blood agar for 24 h (37°C, 5% CO2) to check for the residual presence of nonmycoplasmal species.
Statistical analysis. (i) Crosstabulation. First, the diagnostic accuracy (sensitivity and specificity) of
both the RIMM and the selective-indicative agar (index tests) was determined with real-time PCR as the
reference test (WinEpi, Zaragoza, Spain). BALf was considered positive for M. bovis when the ID-score of
MALDI-TOF MS was 1.7 (direct identification) after 72 h of incubation, when the CT score was 40
(real-time PCR), or when Mycoplasma-like colonies showed lipase activity (bacterial culture). For 4 BALf
samples, no results for 72 h of incubation were obtained (due to a practical problem), and for these
samples, results from 48 h were used to compare with real-time PCR and the selective-indicative agar.
(ii) Bayesian latent class modeling. (a) Definition of outcome tested. The sensitivity and specificity
of the real-time PCR are not 100% (32, 33). Therefore, and also because of issues with clinical interpre-
tation (detection of a small amount of nonviable pathogens), this test cannot truly be considered a gold
standard. To account for this issue, a second statistical analysis was performed to determine the
diagnostic accuracy of the three methods. Bayesian latent class models create their own probabilistic
definition of the outcome studied, depending on what the tests actually detect. In this study, PCR detects
DNA from either living or dead bacteria. The selective-indicative agar detects culturable bacteria with
lipase activity. Culture enrichment combined with MALDI-TOF MS detects protein spectra from culturable
bacteria. Therefore, in our judgement, the three tests detect three distinguishing parameters, and a
model for three independent tests was built. In addition, the model for dependent tests (with both
culture-based methods being dependent of each other) was built to compare independent and depen-
dent outcomes.
(b) Model development. In order to assess the accuracy of the three tests—(i) real-time PCR (detection
of DNA), (ii) RIMM (detection of proteins), and (iii) selective-indicative agar (detection of lipase activi-
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ty)—to detect the presence of M. bovis, a latent class model (1 population, 3 tests) was considered, with
each test regarded as independent from the others. The unknown parameters of interest were sensitivity
and specificity of the three diagnostic tests and the prevalence of M. bovis in the study population. Once
the likelihood of the process generating the data observation is described, which in this case is a
multinomial probability distribution, the estimation of posterior densities can be obtained using the
Bayes theorem, which links the likelihood with the posterior distribution (inference). At this stage, prior
information on any parameter in the likelihood can be added to obtain posterior densities of the different
parameters using a Markov chain Monte-Carlo algorithm (Gibbs sampling). The prior information is a way
to narrow parameter uncertainty when previous scientific information is available. In terms of prevalence
and the Se/Sp of tests, the priors are modeled using beta distributions that are naturally bound from 0
to 1. Priors can be uninformative (any value has same probability of happening) or informative (some
values are more or less probable) (34).
(c) Prior distribution determination process. Prior information was derived from the available literature
and expert opinion. For both RIMM and the selective-indicative agar, no literature information was
available. Previous work on M. bovis real-time PCR estimated an Se of 95.2% (95% confidence interval
[CI95], 76.1% to 99.9%) and Sp of 73.9% (CI95, 51.6% to 89.8%) (32). Also, for the prevalence of M. bovis
in the population, prior information was available (7, 35). This literature information was combined with
the best guesses of experts in the field (first author and senior authors). The 5th percentiles were guessed
at 90%, 95%, and 50% for Se, Sp, and prevalence, respectively. These values were used to determine the
beta distribution parameters of the corresponding prior distribution using a free online beta distribution
calculator (Epitools, Sergeant, ESG, Ausvet Animal Health Services and Australian Biosecurity calculator;
available at https://epitools.ausvet.com.au/), resulting in beta (99.7, 6.19), beta (1), and beta (6.28, 13.32)
for Se, Sp, and prevalence, respectively.
In total, the three following models were run: the first model with all prior information on all
parameters set at uninformative (beta 1,1), the second model with informative priors on the Se and Sp
of real-time PCR, and the third model with informative priors on the M. bovis prevalence and
real-time PCR.
The parameters of interest were determined based on a sample from the posterior distribution using
Gibbs sampling with WinBUGS statistical freeware version 1.4.3. (MRC Biostastics Unit, Cambridge, UK).
Estimation of posterior densities and model assessment was done using recommended techniques (36).
A total of 100,000 iterations were used for each model after a burn-in of 5,000 iterations. Three chains
were run with different initial values. The posterior median and 2.5 to 97.5 credible intervals (CI) were
extracted for each parameter. Model convergence was checked by visual inspection of density and
Gelman-Rubin plots. Plots of chain autocorrelation were inspected to investigate the need for thinning
of chains.
For smaller data sets, informative prior elicitation can be a process that could potentially have an
impact on posterior density. Therefore, a sensitivity analysis was performed, running alternative models
with very different prior specifications to the main model. It was determined whether posterior estimates
of these alternative models were included in the 95% CI of the main model (34).
RESULTS
Development of a protocol for fast MALDI-TOF detection of M. bovis in BALf.
Determination of an enrichment procedure and antimicrobial concentrations.
After 48 h of incubation, M. bovis strains were identified with MALDI-TOF MS as M. bovis
(ID-score, 2.0) after protein extraction for all tested antimicrobial concentrations.
Therefore, a concentration of 32 g/ml for both meropenem and vancomycin was
selected for further testing.
Diagnostic test study. Triplex real-time PCR resulted in 26.9% (28/104) positive
BALf samples (CT, 35), 11.5% (12/104) were doubtful (35  CT  40), and 61.5%
(64/104) were negative (CT, 40 or no detection) for M. bovis. For M. bovirhinis, 79.8%
(83/104) were positive, 11.5% (12/104) were doubtful, and 8.7% (9/104) were negative,
and for M. dispar, these figures were 92.3% (96/104), 3.8% (4/104), and 3.8% (4/104),
respectively (see Table S1 in the supplemental material).
After 24 h of enrichment, with the RIMM method, 2.9% (3/104) of the BALf samples
were positive for M. bovis, and after 48 and 72 h, 30.7% (32/104) and 38.0% (38/100),
respectively, were positive. For 4 samples, no results were obtained after 72 h of
incubation, because of a practical problem. ID-scores for M. bovis ranged from 1.74 to
2.65 and are shown in Table S1. M. bovirhinis was identified after 24 h (BALf sample no.
18, 23, 28, 60, and 95), 48 h (BALf sample no. 26, 28, 29, 32, 35, 38, 43, 60, 64, and 102),
and 72 h (BALf sample no. 60, 63, 66, and 88) with ID-scores of 1.70 to 1.88. In BALf
sample no. 24, M. ovipneumoniae was identified after 48 and 72 h of incubation
(ID-score, 1.78 and 1.72, respectively). M. dispar was not detected with the RIMM
method in any sample throughout the experiment.
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Out of 104 samples, 28 (26.9%) showed lipase-positive Mycoplasma-like colonies on
the selective-indicative agar (Table S1), ranging from 1.0  101 to 4.6  104 CFU/ml
BALf (mean, 3.8  103; median, 3.3  102). Of those 104 BALf samples, 18% (19/104) did
not show additional bacterial growth on blood agar plates, whereas 81.7% (85/104) did,
among which were multiple pathogens and commensals (Table S1). Despite the
presence of these nonmycoplasmal bacteria in the original BALf samples, the selective
enrichment phase did not allow nonmycoplasmal bacterial growth to an extent that
was detected by MALDI-TOF MS.
Residual contamination was checked after 72 h of enrichment. There was no
microbial growth on blood agar in 70% of the BALf samples after 24 h of incubation
(70/100). For the samples with microbial growth on blood agar, MALDI-TOF MS
identified Candida spp. (4/30), Aspergillus fumigatus (2/30), Stenotrophomonas malto-
philia (1/30), and Staphylococcus spp. (1/30). In 23 out of 30 blood agars showing
microbial growth, no identification was possible with MALDI-TOF MS, but their mac-
roscopic appearance suggested mainly fungal contaminants.
The 2  2 contingency tables of the RIMM method and the selective-indicative agar
compared with real-time PCR as the reference test are shown in Table 1. The sensitivity
(Se) and specificity (Sp) for the RIMM compared to real-time PCR were 75.0% (CI95,
61.6% to 88.4%) and 85.9% (CI95, 77.4% to 94.5%), respectively. The selective-indicative
agar showed a 60.0% (CI95, 44.8% to 75.2%) Se and a 93.8% (CI95, 87.8% to 99.7%) Sp
compared to the real-time PCR test.
All latent class models converged, and the prior distributions and posterior summary
statistics of each model are shown in Table 2. Parameters were particularly stable
between models, and the results obtained from the sensitivity analysis were highly
robust to changes in the prior distributions. Model 3 included the most prior informa-
TABLE 1 2  2 contingency table for direct MALDI-TOF MS identification as index test
compared to real-time PCR as reference test for identification of Mycoplasma bovis from





(real-time PCR) (%) (no.)
Total no.
of testsPositive Negative
MALDI-TOF MS Positive 75 (30/40) 14 (9/64) 39
Negative 25 (10/40) 86 (55/64) 65
Total no. 40 64 104
Selective-indicative agar Positive 60 (24/40) 6 (4/64) 28
Negative 40 (16/40) 94 (60/64) 76
Total no. 40 64 104
TABLE 2 Posterior median and 95% CI of three independent Bayesian latent class models for the prevalence of M. bovis, sensitivity and
specificity of the RIMM, triplex real-time PCR and selective-indicative agar used to diagnose M. bovis from bronchoalveolar lavage fluid
samples
Parametera
Model 1b Model 2c Model 3d
Prior densities
Posterior densities
(95% CI) Prior densities
Posterior densities
(95% CI) Prior densities
Posterior densities
(95% CI)
Sepcr Beta (1) 93.5 (77.2–99.7) Beta (99.7, 6.19) 94.8 (89.8–97.8) Beta (99.7, 6.19) 94.8 (89.9–97.9)
Sppcr Beta (1) 89.2 (78.1–97.8) Beta (1) 89.1 (78.1–97.7) Beta (1) 88.9 (78.0–97.4)
Serimm Beta (1) 86.0 (68.3–97.5) Beta (1) 86.3 (68.8–97.5) Beta (1) 86.6 (69.4–97.6)
Sprimm Beta (1) 86.8 (76.3–94.9) Beta (1) 86.5 (76.2–93.9) Beta (1) 86.4 (76.1–93.8)
Sesia Beta (1) 69.5 (50.8–86.7) Beta (1) 70.2 (51.8–86.9) Beta (1) 70.5 (52.1–87.1)
Spsia Beta (1) 94.1 (86.0–98.8) Beta (1) 94.0 (86.0–98.5) Beta (1) 93.9 (85.9–98.4)
Prev Beta (1) 33.7 (23.2–45.9) Beta (1) 33.3 (23.1–44.6) Beta (6.28, 13.32) 32.6 (23.5–42.6)
apcr, triplex real-time PCR; Prev, prevalence of M. bovis; rimm, rapid identification of M. bovis with MALDI-TOF MS method; Se, sensitivity; sia, selective-indicative agar;
Sp, specificity.
bModel 1, no informative priors.
cModel 2, informative priors on prevalence and Sepcr (mode, 95%; 5th percentile, 90%) and Sppcr (mode, 74%; 5th percentile, 95%) (30).
dModel 3, informative prior on Sepcr, Sppcr, and prevalence of M. bovis in BALf (mode. 30%; 5th percentile; 50%) (33).
Rapid Identification of Mycoplasma bovis from BALf Journal of Clinical Microbiology
June 2020 Volume 58 Issue 6 e00004-20 jcm.asm.org 5
 on M










tion and is therefore expected to be the most accurate. The prevalence of M. bovis was
32.6% (CI, 23.5% to 42.6%), which was comparable to the prior information added to
the third model. In independent model 3, RIMM showed an Se and Sp of 86.6% (CI,
69.4% to 97.6%) and 86.4% (CI, 76.1% to 93.8%), respectively. Real-time PCR had an Se
of 94.8% (CI, 89.9% to 97.9%) and an Sp of 88.9% (CI, 78.0% to 97.4%). The selective-
indicative agar had an Se and Sp of 70.5% (CI, 52.1% to 87.1%) and 93.9% (CI, 85.9% to
98.4%), respectively. No significant differences between the independent and depen-
dent models were observed.
DISCUSSION
The objective of the present study was to achieve a proof of concept for rapid
identification of M. bovis from bovine BALf samples after enrichment with MALDI-TOF
MS and to compare these with another culture-based method (selective-indicative
agar) and a DNA-based reference test (real-time PCR). In this study, we identified M.
bovis from the majority of BALf samples with RIMM within 2 days after incubation, and
even more after 3 days. The current protocol reduced the relevant growth of nonmy-
coplasmal bacteria and nonpathogenic Mycoplasma spp. present in BALf, resulting in
high sensitivity (86.6%; CI, 69.4 to 97.6) and specificity (86.4%; CI, 76.1 to 93.8) of this
diagnostic test as determined by BLCM. Prior information of the BLMC was extracted
from peer-reviewed journals, and the sensitivity analysis for robustness of all models
was verified. These methods together make the possibility of bias due to the best
guesses of the experts in the field less likely.
False negatives of the RIMM method compared to real-time PCR can be explained
by the viability of M. bovis. PCR detects DNA, while for culture-based methods, such as
MALDI-TOF MS, bacteria need to be alive. Some of the sampled calves might have been
treated with antimicrobials before BALf samples were obtained, resulting in nonviable
M. bovis in the lungs, so only DNA could be detected. This would suggest that no active
M. bovis infection is currently present, and the clinical relevance of positive results from
the real-time PCR might be questioned, in contrast to culture-based methods (RIMM
and selective-indicative agar). In addition, cross-reaction with Mycoplasma agalactiae
has been described for the currently used real-time PCR (32), while MALDI-TOF MS has
been described to accurately distinguish M. bovis and M. agalactiae (17, 18). Both
previous arguments therefore more likely result in a false-positive PCR result rather
than a false-negative culture-based result, and therefore the current specificity of the
RIMM might be underestimated.
Disagreement between a negative result for M. bovis with real-time PCR but a
positive result with the RIMM method might be explained by the fact that the BALf
volume used for RIMM was 4 ml, while the volume was only 200 l for the real-time PCR
reference test and 100 l for biochemical identification (lipase activity) on agar. BALf
contains mucus clumps and cells, which could lead to a heterogenic suspension of M.
bovis. Although samples were vortexed vigorously, it is possible that certain parts of the
BALf did not end up in the aliquot for real-time PCR. This could have caused a higher
chance of isolation using the RIMM method compared with detection using real-time
PCR or selective-indicative agar. The ability to process larger volumes with the RIMM
method from BALf without extra labor is an advantage over both other tests (real-time
PCR and selective-indicative agar) and might even increase the sensitivity of culture-
based methods. Considering (i) that most clinical samples in this study contained 102
to 103 CFU/ml, (ii) the generation time of M. bovis (2 h in exponential phase) (37), and
(iii) that the detection limit of the MALDI-TOF MS is 108 CFU/ml (18), detection of M.
bovis from BALf after 48 h of incubation can be expected and is in line with the
observations. For samples in which M. bovis was detected after 72 h of incubation at the
earliest, for example, the presence of other pathogens, mucus composition, number of
inflammatory cells, or other antimicrobial substances might have influenced the M.
bovis growth rate or MALDI-TOF MS identification efficacy.
Various antimicrobials were added to the modified PPLO broth, as high antimicro-
bial resistance levels against different antimicrobials were observed in bacteria isolated
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from cattle (38–40). Meropenem was considered due to its broad spectrum and strong
activity against Gram-negative bacteria, although this would probably not suppress all
bacterial growth in BALf, as for example, methicillin-resistant Staphylococcus aureus
(MRSA) shows resistance against meropenem in humans but is also a common patho-
gen in calves (41). Therefore, vancomycin was used as well. Until now, only very low
levels to no resistance is detected against this antibiotic in MRSA and Enterococcus
strains obtained from cattle (42, 43). It should be kept in mind that critically important
antibiotics, even though used under laboratory circumstances, should be properly
disposed of after use.
Even though the current method was able to suppress nonmycoplasmal bacterial
growth, there is still room for improvement for the reduction of yeast and fungal
growth. In five of the BALf samples with a false-negative MALDI-TOF MS result com-
pared to real-time PCR, fungal growth was observed, and this might have caused
interference with identification of M. bovis, as fungal pigments can suppress the
desorption process (44) or may lead to the presence of interfering peaks. Adding an
antimycotic drug, such as amphotericin B, might help increase the sensitivity of the
rapid MALDI-TOF MS identification method (45).
The real-time PCR cannot be seen as the gold standard technique for several
reasons. First, sensitivity and specificity are not 100% (32). Second, studies concluded
that the sensitivity of culture was sometimes higher than that of real-time PCR assays
(24, 33), and in this study 11.5% of the real-time PCR results were doubtful and
therefore difficult to compare to the culture-based methods where culture was either
positive or negative. Therefore, a third test was included in this study to perform a
BLCM, as is recommended when no gold standard is available (36).
The selective-indicative agar using lipase activity to identify M. bovis is not widely
used and is therefore somewhat controversial. Though national laboratories in Belgium
have used this method for years, this study is the first to show its diagnostic accuracy.
This method resulted in a moderate sensitivity (70.5%) on the one hand, but on the
other hand, a specificity (93.8%) that was even higher than real-time PCR (88.9%). It has
been described that not all M. bovis strains show lipase activity, which could explain
false negatives, whereas some other Mycoplasma spp. do possess this characteristic,
which could result in false positives (46). Nevertheless, current results show that this
medium might be helpful in M. bovis screenings where low cost is necessary and less
experienced staff is located. It could also be helpful in choosing relevant colonies on
agar plates for subsequent identification methods, such as real-time PCR. In addition, it
cannot be ruled out that the use of other selective-indicative agar media, commercially
available or not, could have resulted in different sensitivity or specificity data.
Other Mycoplasma spp. were identified as well in the BALf. Real-time PCR showed
that at least 79.8% of the BALf samples were positive for M. bovirhinis, and 92.3% were
positive for M. dispar. However, only 15.4% were positive for M. bovirhinis using the
RIMM method with MALDI-TOF MS after 72 h of enrichment. Mixtures of M. bovis, M.
bovirhinis, and M. dispar in BALf of cattle are common (11). Real-time PCR might have
overestimated the prevalence of M. bovirhinis and M. dispar, because M. bovirhinis PCR
cross-reacts with M. canis, and M. dispar PCR cross-reacts with Acholeplasma axanthum
and Mycoplasma alkalescens (32). However, cross-reaction can probably not explain the
large difference observed between the RIMM method and the real-time PCR. The
enrichment medium used in this study seemed to preselect for M. bovis growth. M.
bovirhinis and M. dispar are glucose fermenting, while in our medium only pyruvate was
added as a carbon source (47). The latter is a great advantage in the diagnosis of M.
bovis, as M. bovirhinis and M. bovis can both be identified with MALDI-TOF MS after 2
days of incubation (17). We did, however, observe a shift in identification of M.
bovirhinis, where two samples were positive after 24 h and negative after 48 h. As the
medium was not optimal for M. bovirhinis, one reason for this disparity could be that
the concentration of (viable) M. bovirhinis balanced around the detection limit of the
MALDI-TOF MS. Another reason might be that after 24 h, the concentration of M. bovis
became higher than the concentration of M. bovirhinis, as Pereyre et al. (18) confirmed
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that M. bovis was the only pathogen recognized by MALDI-TOF MS when samples
contained 2 to 3 Mycoplasma species. Irrelevant M. dispar growth is less of a concern in
culture-based methods, as this is a fastidious grower and is more difficult to isolate (47).
Identification of M. ovipneumoniae from bovine BALf was unexpected. However, a
recent study showed this species to be abundantly present in bovine BALf as well (48).
The clinical relevance in cattle is unknown, although M. ovipneumoniae infections can
have serious consequences in small ruminants, such as pneumonia, decreases in lamb
production, and decreases in average daily gain (49, 50). Even though the MALDI-TOF
MS specificity for accurate M. ovipneumoniae detection is not described, Spergser et al.
(17) tested 19 M. ovipneumoniae clinical isolates against their own in-house library,
which resulted in 100% identification with a score value of 1.7 (17).
MALDI-TOF MS is already proven to be of assistance for the identification of human
and veterinary mycoplasmas from culture (17, 18, 29). In the future, there might be a
great opportunity to develop a rapid and specific diagnostic tool to identify other
pathogenic Mycoplasma spp. from BALf as well (for example, M. ovipneumoniae from
small ruminants or Mycoplasma pneumoniae from humans) and accelerate turnover
time in pneumonia diagnostics.
The current study shows that identification of M. bovis from BALf with the RIMM
method is possible within 48 to 72 h after sampling. Compared to real-time PCR, RIMM
is probably less expensive, the clinical relevance might be higher, and when desired, it
holds the opportunity to perform additional susceptibility testing and strain typing (51,
52). Therefore, rapid identification of M. bovis with MALDI-TOF MS is a promising
method for diagnosis of M. bovis in veterinary laboratories. However, it is necessary for
laboratories using this approach for the detection of M. bovis from clinical samples to
fully validate or comprehensively qualify this method. The validation parameters should
include accuracy, precision, linearity and range of measurement, specificity, limit of
detection, limit of quantitation, and robustness.
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